As a molecular marker of cancer upregulated during tumor evolution, PARP-targeted imaging is a promising candidate for efficiently distinguishing neoplastic pathology from other conditions that share hallmarks of brain tumors, including enhancement and hypermetabolism [25]. Here, PARP1 is linked to neoplasm.